Mul­tiple activ­a­tion states of receptors

Mul­tiple activ­a­tion states of receptors

Can recept­ors have dif­fer­ent act­ive states that select­ively trig­ger cer­tain effects? This has long been sus­pec­ted. Now there is a proof.

When a hor­mone or neur­o­trans­mit­ter activ­ates a receptor, the simplest way to ima­gine this is that the receptor switches from “off” to “on.” In its act­ive state (“on”), a receptor gen­er­ates bio­chem­ical sig­nals within the cell on whose sur­face it is loc­ated. These sig­nals lead, for example, to an accel­er­ated heart­beat or increased activ­ity of nerve cells. How­ever, there is a whole range of evid­ence to sug­gest that the pro­cess could be more com­plic­ated. Accord­ing to this new concept, a receptor might assume dif­fer­ent act­ive states depend­ing on which sub­stance activ­ates it. The dif­fer­ent act­ive states could then also trig­ger dif­fer­ent reactions.

A team from Martin Lohse’s former research group at the MDC Ber­lin and the Col­lab­or­at­ive Research Cen­ter 1423 in Leipzig led by Irene Coin and Andreas Bock has now provided dir­ect evid­ence that recept­ors can have mul­tiple act­ive states. The res­ults have now been pub­lished in the journal Nature.

To visu­al­ize the activ­a­tion of recept­ors, doc­toral stu­dent Romy Thomas marked their sur­faces with tiny fluor­es­cent mark­ers. As soon as an activ­ated receptor molecule moved, this led to an increase in fluor­es­cence in some mark­ers and a decrease in oth­ers. This res­ul­ted in a move­ment pat­tern of the receptor.

When the sci­ent­ists activ­ated the labeled recept­ors with dif­fer­ent sub­stances, the changes in fluor­es­cence showed a dis­tinct pro­file for each sub­stance. In other words, each sub­stance triggered very spe­cific, minute move­ments of the receptor molecule and gen­er­ated a spe­cific act­ive state. And each of these states in turn gen­er­ated its own bio­chem­ical reac­tions in the cell.

These obser­va­tions have import­ant con­sequences for drug devel­op­ment, as more than a third of all drugs act via recept­ors. If it is now pos­sible to gen­er­ate spe­cific activ­a­tion states, then it should be pos­sible to develop drugs that have very dif­fer­ent effects on a spe­cific receptor.

At ISAR Bioscience, the Uni­S­ens pro­ject, fun­ded by the European Innov­a­tion Coun­cil, is devel­op­ing an innov­at­ive method to eas­ily meas­ure such spe­cific activ­a­tion states of recept­ors. “The new evid­ence for dif­fer­ent activ­a­tion states of a receptor con­firms the basic hypo­thesis of the Uni­S­ens pro­ject,” says pro­ject man­ager Martha Som­mer. “We want to provide the phar­ma­ceut­ical industry with a uni­ver­sally applic­able detec­tion method for these activ­a­tion states to improve the devel­op­ment of new drugs.”

The graphic shows how a ini­tially inact­ive receptor can dis­play four char­ac­ter­istic move­ment pat­terns after activ­a­tion by four dif­fer­ent sub­stances (right). The move­ment is visu­al­ized via a more or less intense fluor­es­cent glow on the sur­face of the receptor. In this example, the intens­ity of the glow was meas­ured at six dis­tinct points on the sur­face of the receptor. An increase or decrease in the glow is indic­ated by more or less pro­nounced peaks and troughs at the respect­ive meas­ure­ment points. Each sub­stance pro­duced its own pro­file of peaks and troughs, i.e., spe­cific move­ments in the receptor.

Thomas R, Jac­oby PS, De Faveri C, Derieux C, Liebing A-D, Melkes B, Mar­tini H-J, Ber­mudez M, Stäubert C, Lohse MJ, Coin I, Bock A (2026) Lig­and-spe­cific activ­a­tion tra­ject­or­ies dic­tate GPCR sig­nalling in cells, Nature (advanced online publication)

PDF
back BACK